Quick Overview: THE ROLE OF PHARMACOLOGICAL THERAPY IN CHRONIC HEART VALVE DISEASES (Invited Lecture) THE IMPACT OF HYPERTENSION AND ITS TREATMENT IN HEART VALVE DISEASE AORTIC REGURGITATION: IMPACT OF PREOPERATIVE SYMPTOMS FOR POST-VALVE REPLACEMENT SURVIVAL ON ...
International Academy Of Cardiology Jeffrey - Detailed Overview & Context
THE ROLE OF PHARMACOLOGICAL THERAPY IN CHRONIC HEART VALVE DISEASES (Invited Lecture) THE IMPACT OF HYPERTENSION AND ITS TREATMENT IN HEART VALVE DISEASE AORTIC REGURGITATION: IMPACT OF PREOPERATIVE SYMPTOMS FOR POST-VALVE REPLACEMENT SURVIVAL ON ... NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH CORONARY ARTERY DISEASE: RELATIVE RISKS ... NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS): CARDIAC FIBROSIS IN HEART FAILURE (Invited Lecture) Andrew J. Taylor, Ph.D. Alfred Hospital and BakerIDI Heart and ...
SCREENING FOR CVD IN METABOLIC SYNDROME AND DIABETES? (Invited Lecture) Nathan D. Wong, Ph.D Heart Disease ... ANTICOAGULATION AND HEART VALVE DISEASE: IS IT TIME TO RECONSIDER WHO AND HOW? WHOLE HEART REGENERATION WITH HUMAN iPS CELL-DERIVED HEART PROGENITORS (Invited Lecture) Lei Yang, Ph.D. REVERSAL OF CARDIAC REMODELING IN HEART FAILURE BY- ADRENOCEPTOR BLOCKADE (Invited Lecture) Naranjan S. EVOLUTION IN THE MANAGEMENT OF LOW RISK PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITH ... POTENTIAL THERAPY FOR THE PREVENTION OF SUDDEN CARDIAC DEATH (Invited Lecture) Naranjan S. Dhalla, Ph.D., ...
REFINING RISK ASSESSMENT IN DIABETIC DYSLIPIDEMIA AFTER ACHIEVING LDL-C GOAL Om P. Ganda, M.D., Harvard ... REOPERATIVE CARDIAC SURGERY IN ADULT CONGENITAL HEART DISEASE PATIENTS (Invited Lecture) Bassem N. Mora, ... BLOOD PRESSURE TARGETS FOR PATIENTS WITH CORONARY ARTERY DISEASE: IS LOWER BETTER? Clive Rosendorff ... THE SECRET SUPREMACY OF SMALL BLOOD VESSELS, AN ENDURING PUZZLE OF THE UPDATE ON CORONARY BIFURCATION CLASSIFICATION AND TECHNIQUES (Invited Lecture) Mohammad R. Movahed, M.D., ...
